RU2009134910A - COMBINED ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION - Google Patents
COMBINED ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION Download PDFInfo
- Publication number
- RU2009134910A RU2009134910A RU2009134910/15A RU2009134910A RU2009134910A RU 2009134910 A RU2009134910 A RU 2009134910A RU 2009134910/15 A RU2009134910/15 A RU 2009134910/15A RU 2009134910 A RU2009134910 A RU 2009134910A RU 2009134910 A RU2009134910 A RU 2009134910A
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutical composition
- composition according
- hydrochloride
- pyrazinamide
- levofloxacin
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract 9
- 230000002365 anti-tubercular Effects 0.000 title claims abstract 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract 6
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 claims abstract 4
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims abstract 4
- AEUTYOVWOVBAKS-UWVGGRQHSA-N ethambutol Chemical compound CC[C@@H](CO)NCCN[C@@H](CC)CO AEUTYOVWOVBAKS-UWVGGRQHSA-N 0.000 claims abstract 4
- 229960001618 ethambutol hydrochloride Drugs 0.000 claims abstract 4
- 239000000796 flavoring agent Substances 0.000 claims abstract 4
- 235000019634 flavors Nutrition 0.000 claims abstract 4
- 229960003350 isoniazid Drugs 0.000 claims abstract 4
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 claims abstract 4
- 229960003376 levofloxacin Drugs 0.000 claims abstract 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract 4
- 229960005206 pyrazinamide Drugs 0.000 claims abstract 4
- IPEHBUMCGVEMRF-UHFFFAOYSA-N pyrazinecarboxamide Chemical compound NC(=O)C1=CN=CC=N1 IPEHBUMCGVEMRF-UHFFFAOYSA-N 0.000 claims abstract 4
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims abstract 4
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims abstract 4
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims abstract 4
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims abstract 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims abstract 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims abstract 2
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims abstract 2
- 235000013539 calcium stearate Nutrition 0.000 claims abstract 2
- 239000008116 calcium stearate Substances 0.000 claims abstract 2
- 229940078456 calcium stearate Drugs 0.000 claims abstract 2
- 229940075614 colloidal silicon dioxide Drugs 0.000 claims abstract 2
- 239000003086 colorant Substances 0.000 claims abstract 2
- 229960000913 crospovidone Drugs 0.000 claims abstract 2
- 235000019700 dicalcium phosphate Nutrition 0.000 claims abstract 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims abstract 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims abstract 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims abstract 2
- 229960003943 hypromellose Drugs 0.000 claims abstract 2
- 239000004615 ingredient Substances 0.000 claims abstract 2
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract 2
- 229940057948 magnesium stearate Drugs 0.000 claims abstract 2
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract 2
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract 2
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims abstract 2
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims abstract 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims abstract 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims abstract 2
- 229920001592 potato starch Polymers 0.000 claims abstract 2
- 229940116317 potato starch Drugs 0.000 claims abstract 2
- 229940069328 povidone Drugs 0.000 claims abstract 2
- 229960004063 propylene glycol Drugs 0.000 claims abstract 2
- 235000013772 propylene glycol Nutrition 0.000 claims abstract 2
- 239000007909 solid dosage form Substances 0.000 claims abstract 2
- 239000000600 sorbitol Substances 0.000 claims abstract 2
- 229960002920 sorbitol Drugs 0.000 claims abstract 2
- 235000010356 sorbitol Nutrition 0.000 claims abstract 2
- 239000000126 substance Substances 0.000 claims abstract 2
- 239000000454 talc Substances 0.000 claims abstract 2
- 229910052623 talc Inorganic materials 0.000 claims abstract 2
- 229940033134 talc Drugs 0.000 claims abstract 2
- 235000012222 talc Nutrition 0.000 claims abstract 2
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1. Комбинированная противотуберкулезная фармацевтическая композиция в виде твердой лекарственной формы, включающая терапевтически эффективное количество действующего начала, в качестве которого содержит комбинацию левофлоксацина, изониазида, пиразинамида, этамбутола гидрохлорида, пиридоксина гидрохлорида и фармацевтически приемлемые вспомогательные вещества при следующем соотношении ингредиентов действующего начала, мас.%: ! Левофлоксацин 10,40-31,25 Изониазид 5,70-17,50 Пиразинамид 15,0-46,50 Этамбутола гидрохлорид 13,50-40,50 Пиридоксина гидрохлорид 0,35-1,10 ! 2. Фармацевтическая композиция по п.1, отличающаяся тем, что она выполнена в форме таблетки. ! 3. Фармацевтическая композиция по п.2, отличающаяся тем, что она содержит в качестве вспомогательных веществ крахмал картофельный, кросповидон, кремния диоксид коллоидный, магния стеарат, кальция стеарат, повидон, кальция гидрофосфат, сорбит, тальк, целлюлозу микрокристаллическую, гипромелозу, пропиленгликоль, различные красители, ароматизаторы и/или вкусовые добавки. ! 4. Фармацевтическая композиция по п.2 или 3, отличающаяся тем, что она имеет оболочку. 1. The combined anti-tuberculosis pharmaceutical composition in the form of a solid dosage form comprising a therapeutically effective amount of an active principle, which contains a combination of levofloxacin, isoniazid, pyrazinamide, ethambutol hydrochloride, pyridoxine hydrochloride and pharmaceutically acceptable excipients in the following ratio of active principle ingredients, wt.%% :! Levofloxacin 10.40-31.25 Isoniazid 5.70-17.50 Pyrazinamide 15.0-46.50 Ethambutol hydrochloride 13.50-40.50 Pyridoxine hydrochloride 0.35-1.10! 2. The pharmaceutical composition according to claim 1, characterized in that it is made in the form of tablets. ! 3. The pharmaceutical composition according to claim 2, characterized in that it contains, as auxiliary substances, potato starch, crospovidone, colloidal silicon dioxide, magnesium stearate, calcium stearate, povidone, calcium hydrogen phosphate, sorbitol, talc, microcrystalline cellulose, hypromellose, propylene glycol, various colorants, flavors and / or flavors. ! 4. The pharmaceutical composition according to claim 2 or 3, characterized in that it has a shell.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2009134910/15A RU2009134910A (en) | 2009-09-14 | 2009-09-14 | COMBINED ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2009134910/15A RU2009134910A (en) | 2009-09-14 | 2009-09-14 | COMBINED ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2009134910A true RU2009134910A (en) | 2011-03-20 |
Family
ID=44053494
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2009134910/15A RU2009134910A (en) | 2009-09-14 | 2009-09-14 | COMBINED ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2009134910A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2478389C2 (en) * | 2011-07-12 | 2013-04-10 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Pharmaceutical anti-tuberculosis combined composition |
-
2009
- 2009-09-14 RU RU2009134910/15A patent/RU2009134910A/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2478389C2 (en) * | 2011-07-12 | 2013-04-10 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Pharmaceutical anti-tuberculosis combined composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI2498756T4 (en) | Tablet formulations of neratinib maleate | |
| RU2011134713A (en) | PHARMACEUTICAL COMPOSITIONS, INCLUDING HCV POLYMERASE INHIBITOR PROCEDURE | |
| RU2009134910A (en) | COMBINED ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION | |
| RU2008147739A (en) | COMBINED ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION | |
| JP2018530566A5 (en) | ||
| RU2007125596A (en) | COMBINED TUBERCULOSIS DRUG | |
| RU2008115582A (en) | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PARKINSON'S DISEASE | |
| JP7226697B2 (en) | Blonanserin-containing tablet | |
| RU2009134909A (en) | COMBINED ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION | |
| RU2009114885A (en) | PHARMACEUTICAL COMPOSITION IN THE FORM OF A SOLID ORAL DRUG FORM FOR THE TREATMENT OF DISEASES OF THE GASTROINTESTINAL TRACT | |
| RU2009132616A (en) | PHARMACEUTICAL COMPOSITION OF LONG-TERM ACTION FOR CORRECTION OF PSYCHOSOMATIC MANIFESTATIONS | |
| JP2018184381A (en) | Ezetimibe-containing tablet and method for producing the same | |
| RU2011128758A (en) | PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | |
| CN114945371A (en) | Treatment of mast cell diseases and eosinophilic diseases | |
| KR20140092695A (en) | Oral pharmaceutical composition containing valsartan | |
| RU2015125236A (en) | COMBINED PHARMACEUTICAL MEDICINE CONTAINING A SELECTIVE Slow Calcium CHANNEL BLOCKER AND HMG-CoA REDUCASE INHIBITOR | |
| RU2013157796A (en) | PHARMACEUTICAL COMPOSITION BASED ON MOXIFLOXACIN | |
| MX2025001991A (en) | Adagrasib solid pharmaceutical compositions | |
| RU2010134123A (en) | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALLERGIC DISEASES | |
| RU2009134473A (en) | COMBINED TUBERCULOSIS DRUG | |
| RU2008107437A (en) | COMBINED WASTE EXPANDING MEDICINE | |
| RU2013141086A (en) | PHARMACEUTICAL COMPOSITION HAVING ANTIHYPERTENSIVE ACTION | |
| RU2018117473A (en) | A solid dosage form for the treatment of erectile dysfunction in men containing tadalafil | |
| RU2580303C1 (en) | Composition of pellet drug with proroxanum active ingredient | |
| RU2012121055A (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DISEASES ASSOCIATED WITH ENDOTHELIAL DYSFUNCTION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA91 | Application withdrawn (on applicant's request) |
Effective date: 20110512 |